Serotonin linked to somatic awareness, a condition long thought to be imaginary

pain
Credit: CC0 Public Domain

An international team spearheaded by researchers at McGill University has discovered a biological mechanism that could explain heightened somatic awareness, a condition where patients experience physical discomforts for which there is no physiological explanation.

Patients with heightened somatic awareness often experience —headaches, sore joints, nausea, constipation or itchy skin—that cause emotional distress, and are twice as likely to develop . The condition is associated with illnesses such as fibromyalgia, and temporomandibular disorders, and is thought to be of psychological origin.

"Think of the fairy tale of the princess and the pea," says Samar Khoury, a postdoctoral fellow at McGill's Alan Edwards Centre for Research on Pain. "The princess in the story had extreme sensitivity where she could feel a small pea through a pile of 20 mattresses. This is a good analogy of how someone with heightened somatic awareness might feel; they have discomforts caused by a tiny pea that doctors can't seem to find or see, but it's very real."

Thanks to an existing study on genetic association, Samar Khoury and her colleagues might have found the elusive pea capable of explaining somatic awareness.

Their work, recently published in the Annals of Neurology, used data available through the Orofacial Pain: Prospective Evaluation and Risk Assessment cohort and demonstrates that patients who suffer from somatic symptoms share a common genetic variant. The mutation leads to the malfunctioning of an enzyme critical for the production of serotonin, a neurotransmitter with numerous biological functions.

"I am very happy and proud that our work provides a for heightened ," says Luda Diatchenko, lead author of the new study and a professor in McGill's Faculty of Dentistry. "We believe that this work is very important to patients because we can now provide a biological explanation of their symptoms. It was often believed that there were psychological or , that the problem was in that patient's head, but our work shows that these patients have lower levels of serotonin in their blood."

The results of their study have laid the groundwork for the development of animal models that could be used to better characterize the molecular pathways in heightened somatic . Above all, Diatchenko and Khoury hope their work will pave the way for treatment options.

"The next step for us would be to see if we are able to target serotonin levels in order to alleviate these symptoms," says Diatchenko, who holds the Canada Excellence Research Chair in Human Pain Genetics.


Explore further

Newly discovered pathway for pain processing could lead to new treatments

More information: Samar Khoury et al, A functional substitution in the L‐aromatic amino acid decarboxylase enzyme worsens somatic symptoms via a serotonergic pathway, Annals of Neurology (2019). DOI: 10.1002/ana.25521
Journal information: Annals of Neurology

Provided by McGill University
Citation: Serotonin linked to somatic awareness, a condition long thought to be imaginary (2019, June 19) retrieved 15 July 2019 from https://medicalxpress.com/news/2019-06-serotonin-linked-somatic-awareness-condition.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
143 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more